Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout

Relay Therapeutics, Inc. RLAY Stock Forecast

AI-powered price prediction and analysis for Relay Therapeutics, Inc. ยท Updated May 18, 2026

AI 90-Day Forecast
HOLD
7 Days
โ–ˆโ–ˆ%
30 Days
โ–ˆโ–ˆ%
90 Days
โ–ˆโ–ˆ%
AI Confidence: 23% Spearman Correlation
May 18, 2026

See RLAY's Exact Price Target

Create a free account to unlock AI predictions for 4,000+ stocks

Sign Up Free with Google
โœ“ Free account ยท โœ“ 30-day trial ยท โœ“ Cancel anytime

Price Chart

Loading chart...

Key Statistics

Market Cap
$2.31B
P/B Ratio
3.60x
ROE
-32.2%
Revenue
$10M
Current Ratio
22.13x
D/E Ratio
0.09x

About Relay Therapeutics, Inc.

Relay Therapeutics, Inc. (RLAY) operates in the Life Sciences sector, specifically in the Biological Products, (No Diagnostic Substances) industry. .

We do not have any company description for Relay Therapeutics, Inc. at the moment.

Life Sciences Biological Products, (No Diagnostic Substances) Nasdaq Mid Cap

Biological Products, (No Diagnostic Substances) Peers

Company Ticker AI Signal Market Cap P/E
Acumen Pharmaceuticals, Inc. ABOS โ–ˆโ–ˆ% $165M -x
Abpro Holdings, Inc. ABP โ–ˆโ–ˆ% $310K -x
Abpro Holdings, Inc. ABPO โ–ˆโ–ˆ% $1M -x
Arcellx, Inc. ACLX โ–ˆโ–ˆ% $6.73B -x
Alpha Cognition Inc. ACOG โ–ˆโ–ˆ% $131M -x
Adaptimmune Therapeutics Plc ADAP โ–ˆโ–ˆ% $77M -13.2x
Adma Biologics, Inc. ADMA โ–ˆโ–ˆ% $1.92B 11.6x
Adaptive Biotechnologies Corp ADPT โ–ˆโ–ˆ% $2.05B -x
Adverum Biotechnologies, Inc. ADVM โ–ˆโ–ˆ% $95M -1.8x
Agenus Inc AGEN โ–ˆโ–ˆ% $138M 2.1x
Agentix Corp. AGTX โ–ˆโ–ˆ% $2M -x
Aim Immunotech Inc. AIM โ–ˆโ–ˆ% $4M -x
Aim Immunotech Inc. AIMI โ–ˆโ–ˆ% $1M -x
Alector, Inc. ALEC โ–ˆโ–ˆ% $240M -x
Aligos Therapeutics, Inc. ALGS โ–ˆโ–ˆ% $35M -x
Allogene Therapeutics, Inc. ALLO โ–ˆโ–ˆ% $690M -x
Alvotech ALVO โ–ˆโ–ˆ% $1.03B -x
Amgen Inc AMGN โ–ˆโ–ˆ% $176.11B 22.6x
Apogee Therapeutics, Inc. APGE โ–ˆโ–ˆ% $6.08B -x
Aptose Biosciences Inc. APTOF โ–ˆโ–ˆ% $4M -x
Argenx Se ARGX โ–ˆโ–ˆ% $49.46B -x
Armata Pharmaceuticals, Inc. ARMP โ–ˆโ–ˆ% $294M -x
Artiva Biotherapeutics, Inc. ARTV โ–ˆโ–ˆ% $475M -x
Leonabio, Inc. ATHA โ–ˆโ–ˆ% $23M -0.2x
Atara Biotherapeutics, Inc. ATRA โ–ˆโ–ˆ% $82M -x
Atyr Pharma Inc ATYR โ–ˆโ–ˆ% $49M -x
Aura Biosciences, Inc. AURA โ–ˆโ–ˆ% $854M -x
Autolus Therapeutics Plc AUTL โ–ˆโ–ˆ% $434M -x
Anavex Life Sciences โ€ฆ AVXL โ–ˆโ–ˆ% $270M -x
Bioatla, Inc. BCAB โ–ˆโ–ˆ% $7M -x
Biocardia, Inc. BCDA โ–ˆโ–ˆ% $11M -x
Brainstorm Cell Therapeutics โ€ฆ BCLI โ–ˆโ–ˆ% $8M -x
Biocryst Pharmaceuticals Inc BCRX โ–ˆโ–ˆ% $2.29B -x
Black Diamond Therapeutics, โ€ฆ BDTX โ–ˆโ–ˆ% $158M -x
Beam Therapeutics Inc. BEAM โ–ˆโ–ˆ% $2.87B -x
Biogen Inc. BIIB โ–ˆโ–ˆ% $28.40B 20.7x
Biontech Se BNTX โ–ˆโ–ˆ% $22.65B -x
Cabaletta Bio, Inc. CABA โ–ˆโ–ˆ% $540M -x
Candel Therapeutics, Inc. CADL โ–ˆโ–ˆ% $642M -x
C4 Therapeutics, Inc. CCCC โ–ˆโ–ˆ% $370M -x
Cidara Therapeutics, Inc. CDTX โ–ˆโ–ˆ% $6.49B -1.0x
Creative Medical Technology โ€ฆ CELZ โ–ˆโ–ˆ% $8M -x
Cero Therapeutics Holdings, โ€ฆ CERO โ–ˆโ–ˆ% $1M -x
Cullinan Therapeutics, Inc. CGEM โ–ˆโ–ˆ% $967M -x
Compugen Ltd CGEN โ–ˆโ–ˆ% $260M 3.7x
Cg Oncology, Inc. CGON โ–ˆโ–ˆ% $5.89B -x
Cognition Therapeutics Inc CGTX โ–ˆโ–ˆ% $102M -x
Coherus Oncology, Inc. CHRS โ–ˆโ–ˆ% $242M 1.3x
Calidi Biotherapeutics, Inc. CLDI โ–ˆโ–ˆ% $3M -x
Cellectis S.A. CLLS โ–ˆโ–ˆ% $394M -x
Compass Therapeutics, Inc. CMPX โ–ˆโ–ˆ% $335M -x
Mosaic Immunoengineering Inc. CPMV โ–ˆโ–ˆ% $5M -x
Caribou Biosciences, Inc. CRBU โ–ˆโ–ˆ% $142M -1.5x
Cardiff Oncology, Inc. CRDF โ–ˆโ–ˆ% $114M -x
Cardiol Therapeutics Inc. CRDL โ–ˆโ–ˆ% $147M -x
Curis Inc CRIS โ–ˆโ–ˆ% $20M -x
Crispr Therapeutics Ag CRSP โ–ˆโ–ˆ% $4.67B -x
Champions Oncology, Inc. CSBR โ–ˆโ–ˆ% $86M -x
Cel Sci Corp CVM โ–ˆโ–ˆ% $21M -x
Dbv Technologies S.A. DBVT โ–ˆโ–ˆ% $1.16B -x
Dbv Technologies S.A. DBVTF โ–ˆโ–ˆ% $10K -x
Ginkgo Bioworks Holdings, โ€ฆ DNA โ–ˆโ–ˆ% $475M -x
Denali Therapeutics Inc. DNLI โ–ˆโ–ˆ% $2.95B -x
Precision Biosciences Inc DTIL โ–ˆโ–ˆ% $188M -x
Dyadic International Inc DYAI โ–ˆโ–ˆ% $26M -x
Editas Medicine, Inc. EDIT โ–ˆโ–ˆ% $256M -x
Eloxx Pharmaceuticals, Inc. ELOX โ–ˆโ–ˆ% $1M -x
Elutia Inc. ELUT โ–ˆโ–ˆ% $44M 0.9x
Engene Therapeutics Inc. ENGN โ–ˆโ–ˆ% $115M -x
Entera Bio Ltd. ENTX โ–ˆโ–ˆ% $59M -x
Viskase Holdings, Inc. ENZN โ–ˆโ–ˆ% $38M -x
Estrella Immunopharma, Inc. ESLA โ–ˆโ–ˆ% $47M -x
Evaxion A/S EVAX โ–ˆโ–ˆ% $33M -x
Exelixis, Inc. EXEL โ–ˆโ–ˆ% $12.72B 15.3x
Exozymes Inc. EXOZ โ–ˆโ–ˆ% $83M -x
Fate Therapeutics Inc FATE โ–ˆโ–ˆ% $204M -x
4d Molecular Therapeutics, โ€ฆ FDMT โ–ˆโ–ˆ% $478M -x
Fennec Pharmaceuticals Inc. FENC โ–ˆโ–ˆ% $337M -x
Finch Therapeutics Group, โ€ฆ FNCH โ–ˆโ–ˆ% $12M 0.5x
Finch Therapeutics Group, โ€ฆ FNCHQ โ–ˆโ–ˆ% $12M 0.5x
Futuretech Ii Acquisition โ€ฆ FTII โ–ˆโ–ˆ% $52M -x
Futuretech Ii Acquisition โ€ฆ FTIIU โ–ˆโ–ˆ% $14M -x
Gilead Sciences, Inc. GILD โ–ˆโ–ˆ% $160.94B 17.5x
Monte Rosa Therapeutics, โ€ฆ GLUE โ–ˆโ–ˆ% $1.53B -x
Genenta Science S.P.A. GNTA โ–ˆโ–ˆ% $15M -x
Green Planet Bio โ€ฆ GPLB โ–ˆโ–ˆ% $340K -x
Greenland Mines Ltd GRML โ–ˆโ–ˆ% $47M -x
Halozyme Therapeutics, Inc. HALO โ–ˆโ–ˆ% $7.96B 22.8x
Humacyte, Inc. HUMA โ–ˆโ–ˆ% $206M -x
Immunitybio, Inc. IBRX โ–ˆโ–ˆ% $8.35B -x
Inhibikase Therapeutics, Inc. IKT โ–ˆโ–ˆ% $228M -x
Imagenebio, Inc. IMA โ–ˆโ–ˆ% $64M -x
Immunocore Holdings Plc IMCR โ–ˆโ–ˆ% $1.43B -x
Immatics N.V. IMTX โ–ˆโ–ˆ% $1.46B -x
Immunovant, Inc. IMVT โ–ˆโ–ˆ% $5.59B -x
In8bio, Inc. INAB โ–ˆโ–ˆ% $15M -x
Inhibrx Biosciences, Inc. INBX โ–ˆโ–ˆ% $873M -6.8x
Mink Therapeutics, Inc. INKT โ–ˆโ–ˆ% $51M -x
Inmune Bio, Inc. INMB โ–ˆโ–ˆ% $41M -x
Intensity Therapeutics, Inc. INTS โ–ˆโ–ˆ% $12M -x
Iovance Biotherapeutics, Inc. IOVA โ–ˆโ–ˆ% $1.51B -x
Century Therapeutics, Inc. IPSC โ–ˆโ–ˆ% $421M -x
Invivyd, Inc. IVVD โ–ˆโ–ˆ% $342M -x
Jasper Therapeutics, Inc. JSPR โ–ˆโ–ˆ% $24M -x
Kalaris Therapeutics, Inc. KLRS โ–ˆโ–ˆ% $113M -x
Klotho Neurosciences, Inc. KLTO โ–ˆโ–ˆ% $56M -x
Kodiak Sciences Inc. KOD โ–ˆโ–ˆ% $2.30B -x
Krystal Biotech, Inc. KRYS โ–ˆโ–ˆ% $9.02B 40.1x
Kymera Therapeutics, Inc. KYMR โ–ˆโ–ˆ% $6.76B -x
Kyverna Therapeutics, Inc. KYTX โ–ˆโ–ˆ% $574M -x
Ladrx Corp LADX โ–ˆโ–ˆ% $20K -x
Lineage Cell Therapeutics, โ€ฆ LCTX โ–ˆโ–ˆ% $312M -x
Lenz Therapeutics, Inc. LENZ โ–ˆโ–ˆ% $230M -x
Atyr Pharma Inc LIFE โ–ˆโ–ˆ% $2.13B -x
Liminatus Pharma, Inc. LIMN โ–ˆโ–ˆ% $8M -x
Leonabio, Inc. LONA โ–ˆโ–ˆ% $106M -x
Lexeo Therapeutics, Inc. LXEO โ–ˆโ–ˆ% $377M -x
Maze Therapeutics, Inc. MAZE โ–ˆโ–ˆ% $1.41B -x
Mesoblast Ltd MESO โ–ˆโ–ˆ% $1.94B -x
Meiragtx Holdings Plc MGTX โ–ˆโ–ˆ% $871M -x
Metagenomi Therapeutics, Inc. MGX โ–ˆโ–ˆ% $49M -x
Molecular Partners Ag MOLN โ–ˆโ–ˆ% $155M -x
Moderna, Inc. MRNA โ–ˆโ–ˆ% $19.47B -x
Neurocrine Biosciences Inc NBIX โ–ˆโ–ˆ% $15.94B 23.8x
Nkgen Biotech, Inc. NKGN โ–ˆโ–ˆ% $2M -0.1x
Neumora Therapeutics, Inc. NMRA โ–ˆโ–ˆ% $331M -x
Novavax Inc NVAX โ–ˆโ–ˆ% $1.49B -x
Ocugen, Inc. OCGN โ–ˆโ–ˆ% $470M -x
Outlook Therapeutics, Inc. OTLK โ–ˆโ–ˆ% $28M -x
Palisade Bio, Inc. PALI โ–ˆโ–ˆ% $306M -x
Passage Bio, Inc. PASG โ–ˆโ–ˆ% $17M -x
Vaxcyte, Inc. PCVX โ–ˆโ–ˆ% $7.56B -x
Biomx Inc. PHGE โ–ˆโ–ˆ% $5M -x
Pluri Inc. PLUR โ–ˆโ–ˆ% $35M -x
Protalix Biotherapeutics, Inc. PLX โ–ˆโ–ˆ% $158M 10.3x
Pharmacyte Biotech, Inc. PMCB โ–ˆโ–ˆ% $9M -x
Prime Medicine, Inc. PRME โ–ˆโ–ˆ% $529M -x
Prokidney Corp. PROK โ–ˆโ–ˆ% $501M -x
Pelthos Therapeutics Inc. PTHS โ–ˆโ–ˆ% $90M -x
Qiagen N.V. QGEN โ–ˆโ–ˆ% $7.15B -x
Quince Therapeutics, Inc. QNCX โ–ˆโ–ˆ% $19M 2.2x
Qrons Inc. QRON โ–ˆโ–ˆ% $150K -x
Replimune Group, Inc. REPL โ–ˆโ–ˆ% $416M -x
Repligen Corp RGEN โ–ˆโ–ˆ% $5.80B 112.9x
Regenxbio Inc. RGNX โ–ˆโ–ˆ% $295M -x
Relay Therapeutics, Inc. RLAY โ–ˆโ–ˆ% $2.31B -x
Revolution Medicines, Inc. RVMD โ–ˆโ–ˆ% $29.16B -x
Recursion Pharmaceuticals, Inc. RXRX โ–ˆโ–ˆ% $1.55B -x
Sab Biotherapeutics, Inc. SABS โ–ˆโ–ˆ% $283M -x
Sana Biotechnology, Inc. SANA โ–ˆโ–ˆ% $828M -x
Scilex Holding Co SCLX โ–ˆโ–ˆ% $44M -x
Scinai Immunotherapeutics Ltd. SCNI โ–ˆโ–ˆ% $2M -x
Sangamo Therapeutics, Inc SGMO โ–ˆโ–ˆ% $55M -x
Solid Biosciences Inc. SLDB โ–ˆโ–ˆ% $681M -x
Silexion Therapeutics Corp SLXN โ–ˆโ–ˆ% $1M -x
Senti Biosciences Holdings, โ€ฆ SNTI โ–ˆโ–ˆ% $31M -x
Scholar Rock Holding โ€ฆ SRRK โ–ˆโ–ˆ% $5.88B -x
Surrozen, Inc./De SRZN โ–ˆโ–ˆ% $323M -x
Sutro Biopharma, Inc. STRO โ–ˆโ–ˆ% $646M -x
Protara Therapeutics, Inc. TARA โ–ˆโ–ˆ% $281M -x
Tarsus Pharmaceuticals, Inc. TARS โ–ˆโ–ˆ% $2.69B -x
Tc Biopharm (Holdings) โ€ฆ TCBPY โ–ˆโ–ˆ% $10K -x
Tscan Therapeutics, Inc. TCRX โ–ˆโ–ˆ% $65M -x
Bio-Techne Corp TECH โ–ˆโ–ˆ% $6.78B 61.9x
Tectonic Therapeutic, Inc. TECX โ–ˆโ–ˆ% $525M -x
Instil Bio, Inc. TIL โ–ˆโ–ˆ% $55M -x
Tenaya Therapeutics, Inc. TNYA โ–ˆโ–ˆ% $186M -x
Tourmaline Bio, Inc. TRML โ–ˆโ–ˆ% $1.23B -3.5x
Taysha Gene Therapies, โ€ฆ TSHA โ–ˆโ–ˆ% $1.71B -x
Titan Pharmaceuticals Inc TTNP โ–ˆโ–ˆ% $6M -0.5x
Tevogen Bio Holdings โ€ฆ TVGN โ–ˆโ–ˆ% $33M -x
Twist Bioscience Corp TWST โ–ˆโ–ˆ% $3.06B -x
Voyager Acquisition Corp./Cayman โ€ฆ VACH โ–ˆโ–ˆ% $328M 36.5x
Voyager Acquisition Corp./Cayman โ€ฆ VACHU โ–ˆโ–ˆ% $68M 6.7x
Valneva Se VALN โ–ˆโ–ˆ% $539M -x
Vericel Corp VCEL โ–ˆโ–ˆ% $1.68B 78.5x
Vir Biotechnology, Inc. VIR โ–ˆโ–ˆ% $1.42B -x
Vivosim Labs, Inc. VIVS โ–ˆโ–ˆ% $3M -x
Vor Biopharma Inc. VOR โ–ˆโ–ˆ% $793M -x
Vaxart, Inc. VXRT โ–ˆโ–ˆ% $164M 4.4x
Voyager Therapeutics, Inc. VYGR โ–ˆโ–ˆ% $227M -x
Windtree Therapeutics Inc โ€ฆ WINT โ–ˆโ–ˆ% $670K -x
X4 Pharmaceuticals, Inc XFOR โ–ˆโ–ˆ% $372M -x
Zeo Scientifix, Inc. ZEOX โ–ˆโ–ˆ% $17M -x
Zivo Bioscience, Inc. ZIVO โ–ˆโ–ˆ% $14M -x
Zura Bio Ltd ZURA โ–ˆโ–ˆ% $448M -x

FAQ

  • Is Relay Therapeutics, Inc. a good stock to buy?

    Our AI analyzes Relay Therapeutics, Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.

  • How accurate are Relay Therapeutics, Inc. predictions?

    Our AI achieves a 23% Spearman correlation for this stock, with 67%+ average accuracy across 4,000+ stocks analyzed daily.

  • How often are forecasts updated?

    Relay Therapeutics, Inc. forecasts are updated daily using the latest market data and AI models.

Ready to invest smarter?

Join thousands of investors using AI-powered stock predictions

Sign Up Free
โœ“ Free account ยท โœ“ 4,000+ stocks ยท โœ“ Daily updates

Looking for a deeper analysis of Relay Therapeutics, Inc.?

View full institutional-grade analysis on Intratio โ†’

AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.

My Portfolio

Investment Dashboard

Loading your portfolio...